UniProt ID | Protein Name | Gene Symbol ▼ | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
O42574 | Beta-1 adrenergic receptor |
|
1 | 0 |
|
P98999 | Adenylate cyclase type 9 |
|
3 | 0 |
|
A0A974DFT1 | Peptidase M12B domain-containing protein |
|
1 | 0 |
|
A0A1L8H558 | A disintegrin and metalloproteinase with thrombospondin motifs 5 |
|
1 | 0 |
|
A0A974HXE3 | Peptidase M12B domain-containing protein |
|
1 | 0 |
|
A0A1L8HCN5 | A disintegrin and metalloproteinase with thrombospondin motifs 5 |
|
1 | 0 |
|
A0A8J0UHZ0 | A disintegrin and metalloproteinase with thrombospondin motifs 1 |
|
1 | 0 |
|
Q5U261 | ADAM metallopeptidase with thrombospondin type 1 motif 1 L homeolog precursor |
|
1 | 0 |
|
O42596 | Disintegrin and metalloproteinase domain-containing protein 22 |
|
6 | 0 |
|
Q9PSZ3 | Disintegrin and metalloproteinase domain-containing protein 11 (Fragment) |
|
3 | 0 |
|
Q8JIY1 | Disintegrin and metalloproteinase domain-containing protein 10 |
|
4 | 0 |
|
Q2VQV9 | Adenosine deaminase 2 |
|
4 | 0 |
|
P27041 | Activin receptor type-2B |
|
2 | 0 |
|
P27039 | Activin receptor type-2A |
|
3 | 0 |
|
Q6IP56 | Tartrate-resistant acid phosphatase type 5 |
|
1 | 0 |
|
A0A310UBJ0 | Tartrate-resistant acid phosphatase type 5 |
|
1 | 0 |
|
Q6GNG2 | Tartrate-resistant acid phosphatase type 5 |
|
1 | 0 |
|
Q3KQG9 | Testicular acid phosphatase homolog |
|
9 | 0 |
|
B1H1P9 | Lysosomal acid phosphatase |
|
7 | 0 |
|
A0A8J0UHV7 | Angiotensin-converting enzyme |
|
2 | 0 |
|
A0A1L8HCX9 | Angiotensin-converting enzyme |
|
2 | 0 |
|
A0A974HXD1 | Angiotensin-converting enzyme |
|
2 | 0 |
|
Q6IRP4 | Protein ABHD13 |
|
1 | 0 |
|
A0A974BUD2 | Potassium channel subfamily K member |
|
1 | 0 |
|
A0A974BSW1 | Phosphoinositide phospholipase C |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024